{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06239194",
            "orgStudyIdInfo": {
                "id": "MDX-2001-101"
            },
            "organization": {
                "fullName": "ModeX Therapeutics, An OPKO Health Company",
                "class": "INDUSTRY"
            },
            "briefTitle": "Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors",
            "officialTitle": "A Phase 1/2a, Multicenter, First-in-human, Open-label Clinical Trial Evaluating MDX2001 Monotherapy in Patients With Advanced Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "dose-escalation-and-dose-expansion-study-of-in-patients-with-advanced-solid-tumors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2028-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-01-18",
            "studyFirstSubmitQcDate": "2024-01-26",
            "studyFirstPostDateStruct": {
                "date": "2024-02-02",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "ModeX Therapeutics, An OPKO Health Company",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.",
            "detailedDescription": "This study consists of Phase 1a dose escalation, Phase 1b dose expansion in a single indication, and Phase 2a expansion in a single indication.\n\nPrimary Objectives\n\n* All Phases: Evaluate the safety and tolerability of MDX2001 in patients with advanced solid tumor malignancies\n* Phase 1 only: Identify a recommended Phase 2 dose (RP2D) for further development of MDX2001\n* For Phase 1b and Phase 2: Assess the anti-tumor efficacy of MDX2001 in patients with selected advanced solid tumor malignancies\n\nSecondary Objectives:\n\n* Further characterize the anti-tumor activity of MDX2001 based on additional assessments of clinical benefit\n* Characterize the pharmacokinetics of MDX2001\n* Characterize the immunogenicity of MDX2001\n* Characterize relationship of baseline target protein expression in tumor tissue and clinical benefit\n\nThe expected duration of study intervention for patients may vary, based on progression date. The median expected duration of study per patient is estimated to be 10 months (up to 1 month for screening, a median of 6 months for treatment, and a median of 3 months for long term follow-up)."
        },
        "conditionsModule": {
            "conditions": [
                "Biliary Tract Cancer",
                "Breast Cancer",
                "Cervical Cancer",
                "Colon Cancer",
                "Endometrial Cancer",
                "Esophageal Cancer",
                "Gastric Cancer",
                "GastroEsophageal Cancer",
                "Head and Neck Cancer",
                "Hepatocellular Cancer",
                "Non-small Cell Lung Cancer",
                "Pancreatic Cancer",
                "Prostate Cancer",
                "Rectal Cancer",
                "Renal Cancer",
                "Thyroid Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 115,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Phase 1a - MDX2001 Dose Escalation",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with metastatic solid tumors will receive MDX2001 as intravenous (IV) infusion.",
                    "interventionNames": [
                        "Drug: MDX2001"
                    ]
                },
                {
                    "label": "Phase 1b - Dose Expansion - Dose A",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with a single tumor indication receive MDX2001 as intravenous (IV) infusion.",
                    "interventionNames": [
                        "Drug: MDX2001"
                    ]
                },
                {
                    "label": "Phase 1b - Dose Expansion - Dose B",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with a single tumor indication will receive MDX2001 as intravenous (IV) infusion.",
                    "interventionNames": [
                        "Drug: MDX2001"
                    ]
                },
                {
                    "label": "Phase 2a - Cohort Expansion",
                    "type": "EXPERIMENTAL",
                    "description": "Patients with a single tumor indication will receive MDX2001 as intravenous (IV) infusion at the recommended Phase 2 dose.",
                    "interventionNames": [
                        "Drug: MDX2001"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "MDX2001",
                    "description": "MDX2001 intravenous infusion",
                    "armGroupLabels": [
                        "Phase 1a - MDX2001 Dose Escalation",
                        "Phase 1b - Dose Expansion - Dose A",
                        "Phase 1b - Dose Expansion - Dose B",
                        "Phase 2a - Cohort Expansion"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "All Phases: Adverse events (AEs)",
                    "description": "Incidence and severity of AEs and serious AEs (SAEs) graded according to the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) v5.0 including changes in clinical laboratory parameters",
                    "timeFrame": "Baseline until end of study, up to approximately 9 months"
                },
                {
                    "measure": "Phase 1b and Phase 2a: Objective response rate of MDX2001",
                    "description": "Objective response rate is defined as the proportion of patients who achieve a complete response (CR) or partial response (PR) per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1.",
                    "timeFrame": "From date of enrollment until the end of treatment, up to approximately 6 months"
                },
                {
                    "measure": "Phase 1: Recommended Phase 2 dose (RP2D)",
                    "description": "Recommended Phase 2 dose is determined following the evaluation of MDX2001 safety including the incidences of dose limiting toxicities (DLTs), MDX2001 anti-tumor activity, and MDX2001 pharmacokinetics",
                    "timeFrame": "Baseline until end of study, up to approximately 9 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Phase 1a: Objective response rate of MDX2001",
                    "description": "Objective response rate is defined as the proportion of patients who achieve a complete response (CR) or partial response (PR) per RECIST v1.1.",
                    "timeFrame": "From date of enrollment until the end of treatment, up to approximately 6 months"
                },
                {
                    "measure": "All Phases: Duration of response (DOR)",
                    "description": "Duration of response is defined as the time from first documentation of response (complete response \\[CR\\] or partial response \\[PR\\]) to documentation of objective disease progression or death due to any cause, whichever occurs first",
                    "timeFrame": "From date of enrollment until the end of treatment, up to approximately 6 months"
                },
                {
                    "measure": "All Phases: Time to response (TTR)",
                    "description": "Time to response is defined as the time from first dose to first documentation of response (CR or PR)",
                    "timeFrame": "From date of enrollment until the first documentation of response (CR or PR), approximately 4 months"
                },
                {
                    "measure": "All Phases: Disease control rate (DCR)",
                    "description": "Disease control rate is defined as the proportion of evaluable patients with a best overall response (BOR) of stable disease, CR or PR",
                    "timeFrame": "From date of enrollment until the end of treatment, up to approximately 6 months"
                },
                {
                    "measure": "All Phases: Progression free survival (PFS)",
                    "description": "Progression-free survival is defined as the time from the first dose to the date of disease progression or death (any cause), whichever occurs first",
                    "timeFrame": "From date of enrollment until the end of treatment, up to approximately 6 months"
                },
                {
                    "measure": "All Phases: Pharmacokinetic Parameter Cmax of MDX2001",
                    "description": "Maximum observed plasma concentration",
                    "timeFrame": "From date of enrollment until completion of the 6th cycle of treatment, up to approximately 6 months"
                },
                {
                    "measure": "All Phases: Pharmacokinetic parameter area under the curve (AUC(0-T)) of MDX2001",
                    "description": "Area under the plasma concentration versus time curve",
                    "timeFrame": "From date of enrollment until the completion of the 3rd cycle of treatment, up to approximately 3 months"
                },
                {
                    "measure": "All Phases: Evaluation of MDX2001 immunogenicity",
                    "description": "The presence and persistence of anti-MDX2001 antibodies",
                    "timeFrame": "Baseline until end of study, up to approximately 9 months"
                },
                {
                    "measure": "All Phases: Correlation between tumor antigen expression and anti-tumor activity of MDX2001",
                    "description": "Relationship between H score cell surface target protein expression in tumor tissue at baseline and objective responses with MDX2001",
                    "timeFrame": "Baseline until the end of treatment, up to approximately 6 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must be \u2265 18 years of age\n* Histologically or cytologically confirmed diagnosis of metastatic solid tumors\n* Eastern Cooperative Oncology Group (ECOG) performance status 0-1\n* All patients should have at least 1 measurable disease per RECIST v1.1. An irradiated lesion can be considered measurable only if progression has been demonstrated on the irradiated lesion.\n* All contraceptive use by men and women should be consistent with local regulations regarding the methods of contraception for those participating in clinical studies.\n* Adequate hematologic, hepatic and renal function\n* Capable of giving signed informed consent\n\nExclusion Criteria:\n\n* Any clinically significant cardiac disease\n* Unresolved toxicities from previous anticancer therapy\n* Prior solid organ or hematologic transplant\n* Known untreated, active, or uncontrolled brain metastases\n* Known positivity with human immunodeficiency virus (HIV), known active hepatitis B or C, or uncontrolled chronic or ongoing infectious requiring intravenous treatment.\n* Receipt of a live-virus vaccination within 28 days of planned treatment start\n* Patient not suitable for participation, whatever the reason, as judged by the Investigator, including medical or clinical conditions.\n* Participation in a concurrent clinical study in the treatment period.\n* Known hypersensitivity to MDX2001 or any of its ingredients\n\nThe above information is not intended to contain all considerations relevant to the potential participation in a clinical trial.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Email recommended",
                    "role": "CONTACT",
                    "phone": "(857) 233-9936",
                    "email": "info@modextx.com"
                }
            ],
            "locations": [
                {
                    "facility": "MD Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ecaterina Dumbrava, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "NEXT Oncology",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "David Sommerhalder, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                },
                {
                    "id": "D000001661",
                    "term": "Biliary Tract Neoplasms"
                },
                {
                    "id": "D000007680",
                    "term": "Kidney Neoplasms"
                },
                {
                    "id": "D000008113",
                    "term": "Liver Neoplasms"
                },
                {
                    "id": "D000006528",
                    "term": "Carcinoma, Hepatocellular"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000001660",
                    "term": "Biliary Tract Diseases"
                },
                {
                    "id": "D000014571",
                    "term": "Urologic Neoplasms"
                },
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5546",
                    "name": "Carcinoma, Non-Small-Cell Lung",
                    "relevance": "LOW"
                },
                {
                    "id": "M13110",
                    "name": "Pancreatic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M14335",
                    "name": "Prostatic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5830",
                    "name": "Uterine Cervical Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16718",
                    "name": "Thyroid Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9613",
                    "name": "Carcinoma, Hepatocellular",
                    "asFound": "Hepatocellular Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11113",
                    "name": "Liver Neoplasms",
                    "asFound": "Hepatocellular Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10703",
                    "name": "Kidney Neoplasms",
                    "asFound": "Renal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16064",
                    "name": "Stomach Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M16723",
                    "name": "Thyroid Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5548",
                    "name": "Carcinoma, Renal Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4947",
                    "name": "Biliary Tract Neoplasms",
                    "asFound": "Biliary Tract Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M4946",
                    "name": "Biliary Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17320",
                    "name": "Urologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4387",
                    "name": "Pancreatic Cancer",
                    "asFound": "Pancreatic Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4906",
                    "name": "Renal Cell Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T5486",
                    "name": "Stomach Cancer",
                    "relevance": "LOW"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "asFound": "Esophageal Cancer",
                    "relevance": "HIGH"
                },
                {
                    "id": "T761",
                    "name": "Biliary Tract Cancer",
                    "asFound": "Biliary Tract Cancer",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}